相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
Sigrid Dubois et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells
Lisa L. Liu et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
Markus Granzin et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
Rossana a Tallerico et al.
ONCOIMMUNOLOGY (2017)
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
Mira M. Shenouda et al.
BREAST CANCER RESEARCH (2017)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
T-bet and Eomesodermin in NK Cell Development, Maturation, and Function
Federico Simonetta et al.
FRONTIERS IN IMMUNOLOGY (2016)
Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
Alejandra Leivas et al.
ONCOIMMUNOLOGY (2016)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Ex Vivo-expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
Susann Szmania et al.
JOURNAL OF IMMUNOTHERAPY (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies
Gianfranco Pittari et al.
FRONTIERS IN IMMUNOLOGY (2015)
Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21
Bo Jiang et al.
CELLULAR IMMUNOLOGY (2014)
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion
Alexander Roelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
Yin Liu et al.
CLINICAL CANCER RESEARCH (2013)
Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells
Feng Cui et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2013)
Tumor-primed NK cells: waiting for the green light
May Sabry et al.
FRONTIERS IN IMMUNOLOGY (2013)
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
Mariella Della Chiesa et al.
BLOOD (2012)
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Lishomwa C. Ndhlovu et al.
BLOOD (2012)
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Saar Gill et al.
BLOOD (2012)
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
Timothy O'Sullivan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
Nikolaos Patsoukis et al.
SCIENCE SIGNALING (2012)
PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
Sonia Norris et al.
VIRAL IMMUNOLOGY (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells
Binqing Fu et al.
IMMUNOLOGY (2011)
Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
Wenzheng Jiang et al.
JOURNAL OF IMMUNOLOGY (2011)
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Sandra Lopez-Verges et al.
BLOOD (2010)
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
Tolga Sutlu et al.
CYTOTHERAPY (2010)
Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
Caroline J. Voskens et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Rα complexes
Kutlu G. Elpek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Maturation of mouse NK cells is a 4-stage developmental program
Laura Chiossone et al.
BLOOD (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Maria Berg et al.
CYTOTHERAPY (2009)
Increased proportion of CD56(bright) natural killer cells in active and inactive systemic lupus erythematosus
Danika Schepis et al.
IMMUNOLOGY (2009)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Jerome D. Coudert et al.
BLOOD (2008)
CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients:: a unique subset of NK cells possibly associated with graft-versus-leukemia effect
Xuzhang Lu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection
Kehmia Titanji et al.
IMMUNOLOGY (2008)
Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor
Nikhil S. Joshi et al.
IMMUNITY (2007)
The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors
Casimir de Rham et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells:: Importance for the therapeutic effectiveness of cell transfer immunotherapy
Jianping Huang et al.
JOURNAL OF IMMUNOLOGY (2006)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells
MJ Townsend et al.
IMMUNITY (2004)
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection
AN Vallejo et al.
TRENDS IN MOLECULAR MEDICINE (2004)
CD56+dim and CD56+bright cell activation and apoptosis in hepatitis C virus infection
AW Lin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Killer immunoglobulin-like receptors
L Moretta et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
In vivo survival and homeostatic proliferation of natural killer cells
M Prlic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Natural killer cells, viruses and cancer
A Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2001)
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
MJ Smyth et al.
INTERNATIONAL IMMUNOLOGY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
分享论文
